Products
AAV2 vector system (AAV2 expression system, AAV2 packaging plasmid system)
AAV protocol Download AAV User Manual Download AAV serotype 2 (AAV capsid 2)system-introduction
GeneMedi's AAV2 Vector System (AAV serotype 1 helper-free packaging plasmids system) is including AAV2 Rep-Cap plamid (AAV2-RC plasmid,or called AAV-RC1 plasmid), AAV helper plasmid and AAV expression vectors (overexpression or shRNA).
GeneMedi's AAV expression vectors have been inserted with differernt expression cassettes, containing kinds of verified protomters and reporters including GFP, zsgreen, RFP, mcherry and luciferase. The GeneMedi's AAV expression vectors have been proved very suitalble for unique gene overexpression or shRNA-mediated knock-down (also called RNAi (RNA interference ). You can also achieve gene knock-out(KO) or gene editing using our Crispr-cas9-gRNA AAV expression vector.
AAV2 Rep-Cap plamid supplies the AAV2 Rep(replication) proteins and the AAV2 capsid protein.
The tissue tropism of AAV2 vector has been validated in retina, liver and kidney, with potential applications in tissue-specific gene therapy.
| Product Name | Organization Type | Price(In USD) | Qty (Quantity) | Sum(In USD) |
|---|---|---|---|---|
| AAV2 vector systemCat.No.:P-PK021. AAV2 Rep-Cap plasmid, 5ug2. AAV Helper Plasmid, 5ug3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Academic | 2028 | ||
| AAV2 vector systemCat.No.:P-PK021. AAV2 Rep-Cap plasmid, 5ug2. AAV Helper Plasmid, 5ug3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Industry R&D (excluding CRO&CDMO&CXO) | Inquiry | ||
| AAV2 vector systemCat.No.:P-PK021. AAV2 Rep-Cap plasmid, 5ug2. AAV Helper Plasmid, 5ug3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug Expression vector refers only to B01, if you need other expression vector, please click →AAV Expression Vector list | CRO&CDMO& CXO&CMC& Manufacturing company | Inquiry | ||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | ||||
| Shipping Cost: | 169.00 | |||
| Total: | ||||
AAV2 vector tissue tropism and gene transduction (serotype-specific AAV infection)
The tissue tropism of AAV2 vector has been validated in retina, liver and kidney, with potential applications in tissue-specific gene therapy.
Virus and titer: AAV2 (left) /AAV-DJ (middle) / AAV9 (right), 1×1012 vg/ml Animal: Nude mouse, 2 months Infection site: Subcutaneous transplant of bowel cancer cells Gene delivery method: Tumor injection, 10μl/site, 4 sites in total Determine assay: 3 weeks post infection, frozen section, immunofluorescence microscopy
Other AAV Rep-Cap Plasmid
Facebook
LinkedIn
Twitter
